| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0005-2736(92)90194-Q |
| P698 | PubMed publication ID | 1586658 |
| P2093 | author name string | D Papahadjopoulos | |
| K K Matthay | |||
| M S Newman | |||
| L R Collins | |||
| M C Woodle | |||
| F J Martin | |||
| C Redemann | |||
| J E Hidayat | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 193-200 | |
| P577 | publication date | 1992-04-01 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes | |
| P478 | volume | 1105 |
| Q35118084 | Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice |
| Q37689857 | Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology |
| Q33933468 | Biological barriers to cellular delivery of lipid-based DNA carriers |
| Q35975280 | Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer |
| Q37657893 | Critical appraisal of targeted ultrasound contrast agents for molecular imaging in large arteries |
| Q34084752 | Current status of pH-sensitive liposomes in drug delivery |
| Q40864452 | Design of fusogenic liposomes using a poly(ethylene glycol) derivative having amino groups |
| Q37412398 | Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression |
| Q33569479 | Drug transport to brain with targeted liposomes |
| Q36116855 | Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s |
| Q41949565 | Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes |
| Q42504487 | Effects of poly(ethyleneglycol)-modified hemoglobin vesicles on agonist-induced platelet aggregation and RANTES release in vitro. |
| Q26996159 | Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems |
| Q73883734 | Enhancement of the in vivo circulation lifetime of L-alpha-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization |
| Q39323540 | Evaluation of asymmetric immunoliposomal nanoparticles for cellular uptake |
| Q71198019 | Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes |
| Q34284213 | Exploiting the tumor phenotype using biodegradable submicron carriers of chemotherapeutic drugs. |
| Q37378137 | Fliposomes: pH-Sensitive Liposomes Containing a trans-2-morpholinocyclohexanol-Based Lipid That Performs a Conformational Flip and Triggers an Instant Cargo Release in Acidic Medium |
| Q55652135 | Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies. |
| Q91579285 | Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona |
| Q36878540 | Homoharringtonine delivered by high proportion PEG of long- circulating liposomes inhibits RPMI8226 multiple myeloma cells in vitro and in vivo |
| Q33811463 | Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes |
| Q73626555 | Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes |
| Q36560724 | Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system |
| Q41630238 | Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes |
| Q41920044 | In-vitro and in-vivo evaluation of pH-responsive polymeric micelles in a photodynamic cancer therapy model |
| Q44385446 | Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration |
| Q38383483 | Inorganic nanovectors for nucleic acid delivery |
| Q30658340 | Involvement of serum mannan binding proteins and mannose receptors in uptake of mannosylated liposomes by macrophages |
| Q40507955 | Liposomes as delivery systems in the prevention and treatment of infectious diseases |
| Q28088315 | Liposomes as nanomedical devices |
| Q73076611 | Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: influence of liposome characteristics |
| Q72717020 | Long circulating, cationic liposomes containing amino-PEG-phosphatidylethanolamine |
| Q43786616 | Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge |
| Q34615891 | Long-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci |
| Q45274520 | Long-circulating sterically stabilized liposomes in the treatment of infections |
| Q39196364 | MRI of ICAM-1 upregulation after stroke: the importance of choosing the appropriate target-specific particulate contrast agent |
| Q36138874 | Molecular imaging of brain localization of liposomes in mice using MALDI mass spectrometry. |
| Q43628542 | N-isopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles |
| Q60935924 | Novel PEGylated Liposomes Enhance Immunostimulating Activity of isRNA |
| Q37999793 | Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept |
| Q47897961 | PEGylation of the GALA Peptide Enhances the Lung-Targeting Activity of Nanocarriers That Contain Encapsulated siRNA. |
| Q47446913 | Polymer vesicles in vivo: correlations with PEG molecular weight |
| Q80149577 | Preparation of poly(ethylene glycol)-grafted liposomes with ligands at the extremities of polymer chains |
| Q58622692 | Preparation of surface-modified albumin nanospheres |
| Q46560845 | Prolonged systemic delivery of peptide drugs by long-circulating liposomes: illustration with vasopressin in the Brattleboro rat |
| Q43639873 | Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma |
| Q34129417 | Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). |
| Q30712954 | Spectroscopic characterization of nanoErythrosomes in the absence and presence of conjugated polyethyleneglycols: an FTIR and (31)P-NMR study |
| Q27496024 | Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers |
| Q35559623 | Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties |
| Q46380222 | Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo |
| Q52539461 | Structural and metabolic consequences of liposome-lipoprotein interactions. |
| Q34129410 | Structure and phase behavior of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol). |
| Q30331020 | Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis. |
| Q43654178 | Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages |
| Q43618159 | The aggregation behavior of collagen in aqueous solution and its property of stabilizing liposomes in vitro |
| Q43737331 | The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. |
| Q36129610 | The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate |
| Q43846850 | The presence of PEG-lipids in liposomes does not reduce melittin binding but decreases melittin-induced leakage |
| Q47237668 | The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs |
| Q38002854 | The treatment of breast cancer using liposome technology |
| Q40762751 | Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions. |
| Q35112491 | Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes |
| Q53674491 | Utilizing temperature-sensitive association of Pluronic F-127 with lipid bilayers to control liposome-cell adhesion. |
| Q41383344 | [Pyr1]-Apelin-13 delivery via nano-liposomal encapsulation attenuates pressure overload-induced cardiac dysfunction. |
Search more.